111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
View analysts' price targets and recommendations, and compare them with competitors.
$114.00
Analysts expect the stock price to decrease by 0.24%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
44.20B
The estimated revenue has increased from the previous period.
6.96B
The estimated EBITDA has increased from the previous period.
7.68
The estimated EPS has increased from the previous period.
5.60B
The estimated net income has increased from the previous period.
4.51B
The estimated EBIT has increased from the previous period.
9.90B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
42.85B
Revenue has increased from the previous period.
8.68%
Revenue growth rate is unchanged from the previous period.
6.75B
EBITDA has increased from the previous period.
15.75%
EBITDA margin is unchanged from the previous period.
4.37B
EBIT has increased from the previous period.
10.19%
EBIT margin is unchanged from the previous period.
2.38B
Depreciation has increased from the previous period.
10.13B
Total cash has increased from the previous period.
23.64%
Cash percentage is unchanged from the previous period.
3.32B
Receivables have increased from the previous period.
7.75%
Receivables percentage is unchanged from the previous period.
5.06B
Inventories have increased from the previous period.
11.80%
Inventory percentage is unchanged from the previous period.
3.53B
Accounts payable has increased from the previous period.
8.23%
Payables percentage is unchanged from the previous period.
-2.00B
Capital expenditure has increased from the previous period.
-4.66%
CapEx percentage is unchanged from the previous period.
9.65%
WACC is unchanged from the previous period.
10.90%
Cost of equity is unchanged from the previous period.
4.40%
Cost of debt is unchanged from the previous period.
1.38
Beta is unchanged from the previous period.
729.20M
Diluted shares outstanding is unchanged from the previous period.
13.52B
Total debt is unchanged from the previous period.
68.33B
Total equity is unchanged from the previous period.
81.85B
Total capital is unchanged from the previous period.
16.51%
Debt weighting is unchanged from the previous period.
83.49%
Equity weighting is unchanged from the previous period.
3.30B
EBIAT has increased from the previous period.
3.29B
UFCF has decreased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
56.34B
Terminal value is unchanged from the previous period.
50.72B
Enterprise value is unchanged from the previous period.
6.94B
Net debt is unchanged from the previous period.
43.78B
Equity value is unchanged from the previous period.
60.04
Equity value per share is unchanged from the previous period.
